We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio VANCOUVER, British Columbia — Using ...

— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor ...

TAMPA, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc., (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today ...

Impact of Liposomal Bupivacaine on Healthcare Resource Utilization and Costs in Patients Undergoing Total Knee Arthroplasty ...

TAMPA, Fla., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today ...

FDA expands indications for bupivacaine liposome injectable suspension (Exparel; Pacira BioSciences, Inc.) for use in adult patients as an adductor canal block and a sciatic nerve block in the ...

SAN DIEGO – Surgeons and anesthesiologists are increasingly resistant to using popliteal regional block anesthesia in foot and ankle surgery, but a recent study confirms that it is safe and effective ...

Early studies hint that a nerve block in the neck could help restore long COVID patients' sense of smell, but more research is needed. When you purchase through links on our site, we may earn an ...

NORWELL, Mass.--(BUSINESS WIRE)--July 28, 2006--Concert Medical has announced the launch of BSmart(TM), the first objective nerve block injection pressure monitor for use in regional anesthesia.

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.